ABSTRACT DNA replication forks that are stalled by DNA damage activate an S-phase checkpoint that prevents irreversible fork arrest and cell death. The increased cell death caused by DNA damage in budding yeast cells lacking the Rad53 checkpoint protein kinase is partially suppressed by deletion of the EXO1 gene. Using a whole-genome sequencing approach, we identified two additional genes, RXT2 and RPH1, whose mutation can also partially suppress this DNA damage sensitivity. We provide evidence that RXT2 and RPH1 act in a common pathway, which is distinct from the EXO1 pathway. Analysis of additional mutants indicates that suppression works through the loss of the Rpd3L histone deacetylase complex. Our results suggest that the loss or absence of histone acetylation, perhaps at stalled forks, may contribute to cell death in the absence of a functional checkpoint.
T HE process of DNA replication must ensure accurate chromosome duplication, even when contending with damaged DNA templates. Replication and DNA repair, take place on chromatin templates and, as a consequence, are influenced by chromatin remodelers and covalent histone modifications. The ability of cells to sense and respond appropriately to conditions that affect replication fork progression is crucial to maintain cell viability and genome integrity (Ciccia and Elledge 2010; Labib and De Piccoli 2011; Zeman and Cimprich 2014) . The "checkpoint" that senses DNA damage and stalled DNA replication forks functions as an important anticancer barrier (Bartkova et al. 2005; Gorgoulis et al. 2005) . Many anticancer drugs work by interfering with DNA replication and their efficacy may, therefore, be influenced by the checkpoint status of the cancer. Thus, understanding the processes that maintain stable replication forks through chromatin may contribute to improving therapies.
In Saccharomyces cerevisiae, as in multicellular eukaryotes, DNA damage checkpoints involve DNA damage detection, signal amplification, and signal transduction directed through phosphoinositide 3-kinase-related protein kinases (PIKK; Mec1 and Tel1 in yeast) that activate effector kinases (Rad53, Chk1, and Dun1 in yeast). Checkpoint kinases regulate many aspects of cell metabolism in response to DNA damage (Zegerman and Diffley 2009 ). These include blocking cell cycle progression (Allen et al. 1994) , suppressing late origin firing (Santocanale and Diffley 1998; Shirahige et al. 1998; Santocanale et al. 1999; Lopez-Mosqueda et al. 2010; Zegerman and Diffley 2010) , altering global gene expression patterns (Zhou and Elledge 1993; Allen et al. 1994; Huang et al. 1998) , preventing irreversible DNA replication fork arrest (Lopes et al. 2001; Tercero and Diffley 2001; Tercero et al. 2003) , and upregulating deoxyribonucleoside triphosphate (dNTP) levels (Desany et al. 1998; Zhao et al. 1998) . The regulation of dNTP levels by the DNA damage checkpoint is essential for cell survival, even in the absence of DNA damage. Thus, the survival of mec1D or rad53D checkpoint mutants requires conditions in which dNTP levels have been elevated, such as deletion of the ribonucleotide reductase (RNR) inhibitor Sml1 (Zhao et al. 1998) . However, this is not sufficient to support viability in the presence of DNA damage, such as that caused by methyl methanesulfonate (MMS) or hydroxyurea (HU). We have previously shown that replication forks in rad53D and mec1D mutant strains are unable to progress through damaged DNA, and that reinstating the checkpoint after fork stalling cannot rescue fork progression defects. We proposed that this irreversible replication fork arrest is one of the primary reasons for genotoxicity in these strains (Tercero and Diffley 2001; Tercero et al. 2003) .
Despite its potential importance, we do not understand the nature of the irreversible fork catastrophe in checkpoint mutants, nor do we know how the DNA damage checkpoint protects forks from this fate. Chromatin immunoprecipitation experiments suggested that the checkpoint might prevent loss of replisome components from the fork (Lucca et al. 2004; Cobb et al. 2005) , but more recent work has shown that stalled replisomes appear to be stable even in the absence of a functional checkpoint, both in yeast and human cells (De Piccoli et al. 2012; Dungrawala et al. 2015) . We have taken an unbiased genetic approach to further understand why checkpoint mutant cells are hypersensitive to DNA damage, revealing a connection between chromatin state and replication fork stability.
Materials and Methods

Strains and plasmids
All strains used are listed in Supplemental Material, Table S1 and are derived from W303 (ade2-1 ura3-1 his3-11, 15 trp1-1 leu2-3, 112 can1-100). Genes were deleted by gene replacements of the endogenous wild-type allele via genetic recombination with the corresponding drug-resistant cassettes, obtained by the PCR strategies described previously for KANMX6 (Longtine et al. 1998 ), NATMX6 (Van Driessche et al. 2005 , NATNT2, and HPHNT1 (Janke et al. 2004) . Histone mutants were made by plasmid shuffle and checked by PCR, western blotting, and sequencing with plasmids carrying the wild-type and mutant H3K36R or H3K9R histone genes (pDM9, MBB286, and pWZ414-F53) that were previously described (Quan and Hartzog 2010) .
YEplac112, YEplac112-Rpd3, and YEp-lac112-rpd-3H150A were previously described (Kadosh and Struhl 1998) . The pRS303-RPH1 plasmid was constructed as follows. The RPH1 genomic fragment was amplified by PCR using Phusion DNA polymerase with oligonucleotides 59-ATGCCATCCCGG GACACAAAAAAAGCCCTTATAAC-39 and 59-GCTGCACACTA GTTCAGTTTAAAGGTGTACTCTG-39, digested with XmaI-SpeI, and cloned into XmaI-SpeI-cut pRS303. rph1-H235A, rph1-S652A, and rph1-S652D mutants were created by site-directed mutagenesis of RPH1 and the RPH1 gene was sequenced to verify correct substitution of the selected fragments. The rph1-wild-type and point mutant strains were created by targeting NheI-digested constructs pRS303-RPH1, pRS303-rph1-H235A, pRS303-rph1-S652A, or pRS303-rph1-S652D into the HIS3 locus of an rph1D rad53D strain.
Cell growth, media, and drug sensitivity assays Cells were grown at 30°in YPD medium (1% yeast extract, 2% bacto peptone, and 2% glucose) unless indicated. When backcrossing the isolated checkpoint suppressors with the parental strain, we dissected tetrads and replicated the spores into media containing MMS and phloxine B plates to help distinguish the spores that were surviving MMS. To confirm the suppressor mutations, a minimum of two independent deletions were tested for each gene to exclude mutations that might have arisen during the deletion procedure. We also backcrossed the strain deleted for each tested gene with the parental one to obtain a heterozygous diploid and analyzed the cosegregation of the deletion with the suppressor phenotype after sporulation. In all cases that MMS was used in plates, MMS was added to the melted agar at the indicated concentration just before pouring the plates and the MMS-containing plates were dried with the lid in place for exactly 24-hr before use. Plates were sealed with parafilm during incubation. Dilution-plating assays were a 1:10 dilution series of cultures on the indicated plates and incubated for 3 days at 30°, or irradiated with ultraviolet (UV) radiation at the indicated dosages and then incubated for 3 days at 30°. For the MMS sensitivity assays in a single S phase, the indicated strains were released from G1 arrest at 30°in YPD medium containing 0.015% MMS, and cell survival was scored during a-factor arrest and at the indicated time points. Relative survival was calculated as the percentage of survival of each strain relative to the survival data of the sml1D control strain obtained on the same day. Cell cycle blocks with a-factor were as described previously (Diffley et al. 1994) . Cycloheximide was used at a concentration of 100 mg/ml.
Protein extracts
Proteins were extracted by TCA as described (Foiani et al. 1994) and were then loaded on a 15% acrylamide-bisacrylamide gel, dried, and exposed in a Fujifilm FLA-5000 phosphorimager.
Whole-genome sequencing DNA for whole-genome sequencing was extracted by the CTAB protocol as previously described (Moriel-Carretero and Aguilera 2010) and sheared using the Covaris S2 to 300 bp. The sheared DNA samples were end repaired, poly-A tailed, and Illumina Single-End Adapters were ligated (paired-end protocol; Illumina, San Diego, CA). The standard protocol by Illumina was adjusted to fit our samples. We used Agencourt AMPure XP beads (AMPure bead protocol; Beckman Coulter) at 0.83 ratio to size select out adapter dimers after adapter ligation. The Illumina kit Phusion enzyme was replaced by Kapa HiFi HotStart ready mix (Kapa Biosystems, Cape Town, South Africa). Post PCR, we used AMPure XP beads at a 1:1 ratio to maintain size integrity, which also helped us to optimize the pH and other salt concentrations to allow us to use the Invitrogen SizeSelect E-gel system (SizeSelect gel protocol; Life Technologies). Unlike for the Illumina paired-end sample preparation protocol, we ran the PCR before the gel. This improved visualization of the product and removal of the correct band. To aid us in removing any gel residue that would cause issues in later quality control (QC) and cluster formation, we purified with a QIAquick gel extraction kit (Gel purification protocol; QIAGEN, Valencia, CA). After a final QC step using the DNA 1000 BioAnalyser 2100 chip (Agilent, Santa Clara, CA), the libraries were ready for Flowcell cluster formation on a cluster station followed by Illumina paired-end sequencing on either the Genome Analyzer IIx or HiSeq 2500 with a read length of 36 and 101 bp, respectively. Due to the increased output of the HiSeq 2500, we were able to multiplex 17 samples per lane.
Single-nucleotide variant calling in MMS-resistant suppressor strains Paired-end reads were aligned to the yeast sacCer2 genome assembly using Novoalign 2.07.14 (http://novocraft.com), with the parameters for the mean and SD of the expected size distribution set to 175 and 125, respectively. Alignments for 101-bp paired-end reads were postprocessed for removal of reads that could have arisen from PCR duplication (picardtools 1.81; http://sourceforge.net/projects/picard/). Approximately 96% of paired reads were found to align concordantly to the reference genome resulting in a median coverage of 2003 across all samples.
Base-level nucleotide counts were obtained using deepSNV 1.2.3 (Gerstung et al. 2012 ) with a minimum base quality threshold of 30. Single-nucleotide variant (SNV) calling was performed simultaneously across the relevant sample groups per experiment using scripts written in Python. A minimum allele count of 5 and minimum allele frequency of 0.25 were applied for the rad53D chk1D exo1D (S64Ba vs. W64Aa strain) and exo1D rad53D (YMS6 vs. YGDP939 strain) genome sequencing experiments. These thresholds were increased to a minimum allele count of 20 and minimum allele frequency of 0.40 for the rad53D batch sequencing experiment (MMS-resistant, suppressor-containing strains vs. the YJT75 strain). Multiallelic loci and variants identified in any of the control samples with an allele frequency of 0.1 or above were discarded. Variant annotation was performed with snpEff 3.0j (Cingolani et al. 2012 ) using the sacCer2.61 Ensembl genomic database provided by the package.
SNVs that passed the above criteria were further filtered to only include those that were labeled as nonsynonymous mutations and had a minimum allele frequency of 0.7. Among the top 10 genes that were found to have a recurring missense mutation, 14 mutations were found in genes involved in nonsense-mediated mRNA decay (NMD2, DCP2, XRN1, and UPF3). Thus, we tested the deletions of a total of 32 nonessential genes related to RNA and DNA metabolism (NMD2, XRN1, UPF3, SIR1, SIR4, ESC1, PPH22, MOT2, CTF18, SAC3, RAI1, HRB1, SUM1, YKU70, TDA7, MLP2, SPT7, DAS1, VPS72, STB6, RTT106, BMH2, MPT5, DEF1, LCL3, HFM1, ARP8, NUP100, SWD1, RIF1, BDF2, and NUP170) and identified three pathways: nonsense-mediated mRNA decay, silencing of the mating-type loci HMR and HML (HM loci), and the Rpd3L histone deacetylase (HDAC) complex.
If we apply a less-stringent minimum allele frequency (0.4 instead of 0.7) and consider mutations in Rph1, Rpd3L components (as defined for Rpd3L-expanded, Shevchenko et al. 2008) , chromatin silencing [defined as the gene ontology (GO) processes of "chromatin silencing at silent matingtype cassette," "chromatin-silencing complex," or "negative regulation of gene silencing"], mRNA decay (defined as the GO term "nuclear-transcribed mRNA catabolic process, nonsense-mediated decay"), or MMS hyperresistance, we can assign a mutation to 63 out of the 95 suppressors sequenced.
Given that we did not analyze mutations mapping outside ORFs, which might affect also the gene expression levels of genes related to these pathways, and that there are many possible unknown factors that can affect chromatin acetylation, chromatin silencing, or MMS resistance, probably most of the 95 suppressors sequenced can be explained by one of the three identified pathways, although we cannot rule out other pathways.
Data availability
Strains and plasmids are available upon request. The authors affirm that all data necessary for confirming the conclusions of the article are present within the article, figures, and tables. All raw sequence data and processed SNV calls can be accessed with Gene Expression Omnibus accession GSE113869. Supplemental material available at Figshare: https://doi.org/ 10.25386/genetics.7473365.
Results
Loss of EXO1 and RXT2 suppresses the DNA damage sensitivity of rad53D cells
We previously reported that deletion of the EXO1 gene can suppress the sensitivity of rad53D cells to MMS (Segurado and Diffley 2008) . However, we became aware that the striking resistance to MMS seen in one of our published rad53D exo1D strains (YMS6) was not seen in other genetic backgrounds (K. Labib and G. De Piccoli, personal communication) . This led us to consider that additional mutations in YMS6 may have contributed to its heightened MMS resistance. To test this, we sequenced the genome of YMS6 and compared it to a newly generated exo1D rad53D strain (YGDP939), which did not show such pronounced MMS resistance. We established criteria to define mutations (see Materials and Methods and Table S2 ) and we focused on mutations within ORFs that changed coding sequences. We found seven such mutations. Six were missense mutants, but one was a nonsense mutation in the RXT2 gene (rxt2-Q102STOP), which truncated the last 329 amino acid residues of the encoded protein (Table S2) . We remade this truncation; Figure 1A shows that, like the original mutant, this reconstructed rxt2-Q102STOP partially suppresses the MMS sensitivity of rad53D. Furthermore, complete deletion of the RXT2 gene conferred similar MMS resistance ( Figure  1A) . To examine the effect of RXT2 and EXO1 deletion on viability in a single cell cycle, cells from various strains were synchronized in G1 phase with a-factor mating pheromone and released from the G1 arrest in the presence of MMS. As shown in Figure 1B , rxt2-Q102STOP partially restored the viability lost by rad53D upon passage through S phase in the presence of MMS, indicating that wild-type Rxt2 contributes to cell death in rad53D cells treated with MMS even in a single S phase. Therefore, both rxt2-Q102STOP and exo1D can suppress the DNA damage sensitivity of rad53D cells individually, with rxt2-Q102STOP being a better growth suppressor under chronic MMS treatment. The suppression by rxt2-Q102STOP and exo1D were additive, indicating that they are in different pathways ( Figure 1C ). Thus, mutation/loss of both EXO1 and RXT2 contributed to the suppression of lethality in MMS previously seen in YMS6 (Segurado and Diffley 2008) . Our previous conclusion that deletion of EXO1 suppresses irreversible fork arrest in rad53D cells is likely unaffected by this discovery, since the strains used in the replication fork stability experiments were derived separately from YMS6 and showed MMS sensitivity similar to YGDP939. Moreover, neither viability nor irreversible fork arrest in the rad53D chk1D strain and the mec1D strain were suppressed by deletion of EXO1, consistent with our previous conclusion that these other checkpoint kinases have separate roles in fork stabilization. Nonetheless, the results presented above identified a new Rad53 suppressor (rxt2) and suggested that multiple pathways might contribute to the DNA damage sensitivity of rad53 mutants.
The Rpd3L HDAC contributes to DNA damage sensitivity in rad53D cells
Rxt2 is a subunit of Rpd3L, a HDAC complex whose catalytic subunit is Rpd3. Rpd3L is in "balance" with another HDAC complex, Rpd3S (Carrozza et al. 2005) , which shares several subunits with Rpd3L, including Rpd3. However, each complex also contains several specific subunits (Carrozza et al. 2005) . Whereas Rpd3L localizes primarily to promoter regions to repress transcription, Rpd3S is recruited at the 39-end of transcribed regions (Joshi and Struhl 2005) . To address whether the suppression was due to a defect in Rpd3L HDAC, we studied the effect of deleting other Rpd3L components on the MMS sensitivity of rad53D. Both sds3D and rpd3D suppressed the MMS sensitivity of rad53D as well as rxt2-Q102STOP ( Figure  2A) . However, the deletion of Rpd3S-specific components, such as Eaf3 or Rco1, did not suppress (Figure 2A) . Therefore, suppression is specific to the loss of Rpd3L.
We sought to determine if Rpd3 catalytic activity was involved in the suppression. For this purpose, we expressed Rpd3 and an Rpd3-H150A HDAC catalytic mutant (Kadosh and Struhl 1998) in our rpd3D rad53D sml1D background. As shown in Figure 2B , expression of Rpd3, but not Rpd3-H150A, prevented the suppression, making cells sensitive to MMS.
The deletion of RPD3 had previously been shown to suppress the sensitivity to UV and HU of rad9 and mec1 checkpoint mutants. This suppression was shown to be functional spindle assembly checkpoint-dependent (Scott and Plon 2003) . However, we found that deletion of the spindle assembly checkpoint gene MAD1 had no effect on the suppression of MMS sensitivity in rad53D cells by rpd3D ( Figure S1 ), indicating that the suppression was independent of the spindle assembly checkpoint. Furthermore, although Mec1-and Tel1-dependent cross talk between the DNA damage and the spindle assembly checkpoint has been suggested (Kim and Burke 2008) , deletion of TEL1 had no effect on the suppression by rpd3D ( Figure S1 ).
Identification of RPH1 deletion as a new checkpoint suppressor
To further understand how checkpoints promote viability in the presence of DNA damage, we were interested in identifying other suppressors in an unbiased manner. Given that our previous report (Segurado and Diffley 2008 ) identified exo1D as a suppressor of the DNA damage sensitivity of rad53D but not rad53D chk1D mutant cells, we isolated and characterized colonies from rad53D chk1D exo1D cells that survived on Figure 1 Identification of rxt2 as an extragenic suppressor of the MMS sensitivity of checkpoint mutants. (A) Suppression of the rad53D sensitivity to chronic MMS treatment by exo1D, rxt2-Q102STOP, rxt2D, and double mutants. Strains: YJT72, YJT75, YGDP939, YMS6, 938rxt2, 939rxt2, and YBG628 (B) Suppression of the rad53D sensitivity to MMS by rxt2-Q102STOP, exo1D, and double mutants in a single S phase was studied by treating the indicated strains with 0.015% MMS for the indicated time points after release from G1 synchronization, and scoring cell survival by colony-forming units after plating in fresh media. The mean of at least three experiments is shown. Strains: YBG022, YBG023, YBG245, YBG026, and 939rxt2. (C) Relative survival of S-phase cells treated with MMS 0.015% for 2 hr with respect to the survival of the sml1D control strain (YBG022). Strains: YBG023, YBG245, YBG026, and 939rxt2. The mean and SEM of at least three experiments is shown. * P , 0.05 and ** P , 0.005 (Student's unpaired t-test).
plates containing MMS. One such suppressor was backcrossed five times with the parental strain prior to wholegenome sequencing (see Materials and Methods and Table  S3 ). Among the 12 nonsilent mutations in ORFs, we only found one mutation that caused a protein truncation: a nonsense mutation in the RPH1 gene causing a deletion of the last 340 amino acids of the 796-amino acid Rph1 protein (rph1-R456STOP). We remade this truncation in an unmutagenised genetic background and showed that the rph1-R456STOP truncation promoted levels of survival in the rad53D chk1D exo1D background very similar to those of the strain carrying the original suppressor ( Figure 3A) . rph1-R456STOP also suppressed the sensitivity of rad53D cells to other DNA-damaging agents including UV radiation, camptothecin (CPT), and HU, but this suppression was never as striking as that seen in MMS ( Figure S2A ). The complete deletion of the RPH1 gene also promoted the resistance of rad53D chk1D exo1D cells to DNA damage ( Figure 3B ). Moreover, deletion of RPH1 partially suppressed the MMS sensitivity of rad53D ( Figure 3E ), rad53D chk1D, and mec1D checkpoint mutant strains ( Figure 3B ). Deletion of RPH1 also partially suppressed MMS sensitivity within a single S phase in an a-factor block and release experiment (Figure 3, C and D) .
The deletion of EXO1 improved the survival of rph1D rad53D both in a single-cell cycle experiment (Figure 3 , C and D) and upon chronic exposure to MMS ( Figure 3E ) indicating that, as in the case of Exo1 and Rxt2, Exo1 and Rph1 also act in separate pathways. We wondered whether the suppression caused by rph1 was related to that caused by Rpd3L loss. As shown in Figure 3F , Rxt2 and Rph1 were epistatic for the suppression, indicating that they act in the same pathway.
Loss of Rph1 demethylase activity is not sufficient for suppression
Rph1 is a JmjC domain-containing histone demethylase. Deletion of the other known histone demethylases (Jhd1, Jhd2, or Gis1) did not show any suppression of the rad53D sensitivity to MMS ( Figure 4A ), arguing that the suppression is specific for the loss of Rph1. Rph1 demethylates histone H3 lysine 36 (H3K36) and is the only known demethylase for the trimethylated state of H3K36. If suppression was due to an accumulation of H3K36 methylation, it should require the only known H3K36 methyltransferase, Set2. However, as shown in Figure 4B , rph1D-induced suppression of the rad53D sensitivity to MMS still occurred in set2D cells. Rph1 can also demethylate H3K9 in vitro, although this modification has not been detected in yeast in vivo (Klose et al. 2007) . To exclude the role of H3K36 or H3K9 methylation, we constructed strains in which all copies of the histone H3 and H4 genes (HHT1, HHT2, HHF1, and HHF2) were deleted from the genome and supplemented by a plasmid with a single copy of HHF, and either a wild-type copy of HHT or the nonmethylatable hht2-K36R or hht2-K3K9R mutants (Quan and Hartzog 2010) . As shown in Figure 4C , neither hht2-K36R nor hht2-K3K9R prevented the suppression caused by rph1D. To address if any other histone methylation was responsible for the suppression, we eliminated the other two known histone methyltransferases, Set1 and Dot1, with no effect on rph1D-induced suppression either ( Figure 4B ). These experiments show that rph1D-induced suppression of the rad53D sensitivity to MMS is not caused by the histone demethylase function of Rph1. To test the possibility that suppression might be due to demethylation of some nonhistone substrate, we constructed strains expressing either the wild-type RPH1 gene or a catalytic-deficient rph1-H235A mutant, which disrupts Rph1 demethylase activity (Liang et al. 2011) . In each case, expression was driven by the RPH1 promoter at the HIS3 locus in a rph1D rad53D background. As shown in Figure 4D , both the wild-type Rph1 and rph1-H235A demethylase mutant fully prevented the suppression caused by rph1D. Therefore, the elimination of the Rph1 demethylase function is not sufficient to suppress the MMS sensitivity of rad53D, indicating that Rph1 must have a function independent of its demethylase activity.
Identification of additional suppressor pathways
Finally, we asked whether additional pathways might contribute to suppression. We isolated 100 independent rad53D sml1D suppressors from MMS plates and confirmed their Figure 2 The loss of Rpd3L histone deacetylase suppresses the MMS sensitivity of checkpoint mutants. (A) The nonsense mutation rxt2-Q102STOP, and deletions in Rpd3 or the Rpd3L-specific component Sds3, but not the Rpd3S-specific component Rco1 or Eaf3, suppress the rad53D sensitivity to MMS. Strains: YJT72, YJT75, YBG245, YBG615, YBG369, YBG618, and YBG616. (B) Expression of Rpd3, but not rpd3-H150A histone deacetylase catalytically dead mutant, prevents the suppression by rpd3D. Strains: YJT72+YEplac112, YJT75+YEplac112, YBG369+YEplac112, YBG369+YEplac112-Rpd3, and YBG369+YEplac112-rpd3-H150A. resistance to MMS. We then performed whole-genome sequencing on the 95 remaining MMS-resistant suppressors (see Materials and Methods and Table S4 ). By focusing on nonsilent coding mutations, of which there was an average of 14 per strain, and, in particular, nonsense mutations of which there were a total of 43 across the 95 mutant strains, we were able to prioritize mutations for retesting. We found RPH1, RPD3, and SAP30 mutated in 4 of our 95 suppressors (Table S4) , though we did not find RXT2 or the remaining Rpd3L subunits, indicating that the screen was not saturated. We initially chose 32 genes mutated in the suppressor strains, which had been implicated in nucleic acid metabolism to test further (see Materials and Methods). We found that the sensitivity to MMS of rad53D cells was suppressed by the deletion of 6 of the 31 candidates: the nonsense-mediated mRNA decay (NMD) factors NMD2, UPF3, and XRN1, and the chromatin-silencing factors SIR1, SIR4, and ESC1. nmd2D and upf3D strongly suppress the MMS sensitivity of rad53D cells, while xrn1D can also suppress, despite the fact that xrn1D mutants have a growth defect (Kipling et al. 1991) (Figure 5A ). nmd2D also caused slightly increased resistance to other DNA-damaging agents such as CPT or UV ( Figure 5B ). However, we found that deletion of NMD2 also significantly enhanced the survival of RAD53 cells in MMS, indicating that this effect is not checkpoint-specific ( Figure  5B ) and suggesting that deletion of NMD factors confers a general increased resistance to DNA damage.
The finding that deletion of SIR1, SIR4, or ESC1 suppressed the DNA damage sensitivity of rad53D cells was consistent with previous work (Hu et al. 2001) , and suggested a role for chromatin silencing. We set out to understand how chromatin silencing may be involved in DNA damage sensitivity. In S. cerevisiae, chromatin silencing has been described at three Figure 3 Identification of rph1 as an extragenic suppressor of the MMS sensitivity of checkpoint mutants. (A) Suppression of the rad53D chk1D exo1D sensitivity to MMS by the nonsense mutation rph1-R456STOP. Strains: W303-1A, YJT72, W64Aa, S64Ba, and YBG617. (B) rph1D suppression of the sensitivity to MMS of rad53D chk1D, rad53D chk1D exo1D, and mec1D. Strains: YJT72, YBG611, 2609CRS, YMS167, W6RPH1D1, YJT74, and YBG612. (C) Suppression of the rad53D sensitivity to MMS by rxt2-Q102STOP, exo1D, and double mutants in a single S phase, as in Figure 1B . Strains: YBG023, YBG034, YBG026, and YBG032. (D) Relative survival of S-phase cells as in Figure 1C . * P , 0.05 and ** P , 0.005 (Student's unpaired t-test). Strains: YBG022, YBG023, YBG034, YBG026, and YBG032. (E) Suppression of the rad53D sensitivity to chronic MMS treatment by exo1D, rph1D, and double mutants. Strains: YBG022, YBG023, YBG034, YBG026, and YBG032. (F) Epistatic suppression of the rad53D sensitivity to a single cell cycle (left panel) and chronic MMS treatment (right panel) by rxt2-Q102STOP and rph1D. * P , 0.05 and ** P , 0.005 (Student's unpaired t-test). Strains: YBG022, YBG023, YBG245, YBG034, and YBG348. WT, wild-type.
separate groups of loci: the silent mating-type cassettes (HML and HMR), telomeres, and rDNA. Silencing at the HM loci requires all four SIR genes (SIR1-4), whereas telomere position effect requires SIR2-4 and rDNA silencing requires only SIR2 [reviewed in Rusche et al. (2003) ]. Figure 6A shows that deletion of any one of the four silencing factors suppressed the MMS sensitivity of rad53D. Since Sir1 has only been shown to be required for silencing at the HM loci, this suggested that the suppression might work through deregulated HM expression. Consistent with this, MAT heterozygosity has been shown to confer DNA damage hyperresistance (Friis and Roman 1968; Heude and Fabre 1993; Valencia-Burton et al. 2006) .
If the suppression is due to inappropriate expression of HM loci, then the suppression due to SIR gene deletion should require the presence of the HM loci. As shown in Figure 6B , the deletion of HML in MATa cells fully prevented the suppression caused by sir1D, sir2D, sir4D, and esc1D. Similarly, deletion of HMR in MATa cells fully prevented the suppression caused by sir4D. HM derepression allows haploid yeast cells to express both a-and a-mating-type (MAT) genes, and thus, gene expression patterns are regulated as in diploids. Therefore, we predicted that the deletion of SIR or ESC1 genes should not suppress the DNA damage sensitivity of rad53D/rad53D diploids. As shown in Figure 6C , the enhanced MMS sensitivity of rad53D/rad53D diploid cells was not suppressed when one or both SIR2, SIR4, or ESC1 copies were deleted, confirming that the suppression caused by sir2D, sir4D, and esc1D is a consequence of the matingtype heterozygosity in haploids.
Because Rpd3 antagonizes Sir2-dependent silent chromatin propagation (Zhou et al. 2009 ) and the cellular pool of Sir factors is limiting (Maillet et al. 1996) , we considered the possibility that the suppression observed in the absence of Rpd3L is due to increased Sir spreading and dilution of the silencing at the HM loci. However, the suppression by rph1D and rxt2-Q102STOP was not prevented by HML deletion, nor was it haploid-specific ( Figure S3 ), indicating that this is not a consequence of mating-type heterozygosity.
Discussion
Using an unbiased approach, we found several pathways that contribute to the DNA damage sensitivity of rad53D mutants. Deletion of NMD and mating-type silencing made both rad53D and RAD53 cells more resistant to DNA damage, and were therefore not characterized in detail ( Figure 5 and Figure 6 ; Haber 2012). Loss of NMD has been shown to upregulate the levels of several proteins involved in homologous recombination and increase recombination rates (Janke et al. 2016) , which could explain the suppression we have seen. Although the exact molecular mechanism by which MAT heterozygosity confers more resistance to DNA damage is unknown, some aspects of DNA repair are known to be under mating-type control; for example, nonhomologous end joining is repressed and spontaneous recombination is enhanced in MATa/a cells [reviewed in Haber (2012) ].
Our results indicate that the DNA damage sensitivity of rad53D cells is partially suppressed by loss of the Rpd3L complex ( Figure 1 and Figure 2 ). The loss of Rpd3L does not lead to hyperresistance to MMS in wild-type cells ( Figure  5 ), indicating that Rpd3L specifically contributes to MMS sensitivity primarily in checkpoint-deficient cells. Moreover, suppression is not prevented by HML deletion, nor is it haploid-specific ( Figure S3 ), thus ruling out MAT heterozygosity as an explanation for the suppression. Rpd3L has been shown to inhibit/delay the activation of . 100 replication origins in HU in RAD53 cells (Knott et al. 2009 ). We cannot rule out the possibility that some deregulation of origin firing in the absence of Rpd3L may help suppress MMS sensitivity; however, origin firing is already deregulated in the absence of RAD53, and this deregulation does not make a major contribution to MMS survival (Zegerman and Diffley 2010) . Indeed, deleting RPD3 results in earlier replication of late origins (Vogelauer et al. 2002) , similar to the effect of deleting RAD53. Rpd3 also plays an important role in gene regulation (Rundlett et al. 1996) . However, new protein synthesis is not required for viability in HU (Tercero et al. 2003) or in MMS ( Figure S4 ), arguing that suppression is not due to changes in gene expression.
The possibility we favor is that hyperacetylated chromatin somehow directly promotes replication fork stabilization. Previous data support a positive role for histone acetylation in fork progression (Choy and Kron 2002; Wurtele et al. 2012; Kurat et al. 2017) , and the S-phase checkpoint has been suggested to facilitate DNA replication fork progression during replication stress by increasing chromatin accessibility around replication forks (Rodriguez and Tsukiyama 2013) . Hyperacetylated chromatin might favor replication fork stabilization directly by easing fork progression though a more open chromatin or indirectly by the recruitment of some essential factor for fork stabilization. Alternatively, more accessible DNA might prevent unscheduled recombination at stalled forks or enable recombination-dependent fork restart. Although the consequences of histone acetylation to recombinational repair are currently unclear, it is well established that histone acetylation occurs at double-strand breaks (Bao 2011) and that a complex regulatory network of chromatin marks is involved in tuning recombination mechanisms (Clouaire and Legube 2015) .
Rad53 might thus inhibit Rpd3L or Rph1, perhaps directly at stalled forks. We note that Rph1 has been shown to be a Rad53 target (Kim et al. 2002; Liang et al. 2011) and that its binding to chromatin has been shown to be inhibited by DNA damage (Liang et al. 2011) , opening up the possibility that Rph1 is the essential Rad53 target for DNA damage survival. Among the many putative Rad53 phosphorylation sites in Rph1, Rph1-S652 has been suggested to be involved in the dissociation from chromatin upon UV irradiation (Liang et al. 2011) . However, we have seen that the rph1-S652A phosphodefective mutant is not sensitive to MMS ( Figure S2B ) and that the phosphomimic rph1-S652D does not cause any suppression of the MMS sensitivity of rad53D ( Figure S2B ). Therefore, Rad53 phosphorylation of this site is not sufficient to explain the role of Rad53 in fork stabilization. We cannot rule out the possibility that redundant Rad53 phosphorylation sites in Rph1 are involved in this function or that other Rad53 targets in the Rpd3L complex are involved. Addressing this will require a better understanding of Rad53 substrates.
Given the correlation between tumorigenesis and mutations in the S-phase checkpoints (Bartkova et al. 2005; Gorgoulis et al. 2005) , our observation that HDAC depletion leads to a suppression of lethality of yeast checkpoint mutants is in sharp contrast with the desired toxic effect for HDAC inhibitors in cancer. A large group of malignancies is associated with aberrant HDAC expression and activity, and many HDAC inhibitors have been shown to act synergistically with both chemo-and radiotherapy [reviewed in Kristensen et al. (2009)] . Paradoxically, and in line with our observations, HDAC inhibitors have also been shown to have a radiation-protective effect, as shown for the skin (Chung et al. 2004) . Therefore, the mechanism of fork protection by histone acetylation both in normal and checkpointdefective cells emerges as an interesting mechanism to be further explored.
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